JP Morgan Chase
BOLT icon

JP Morgan Chase’s Bolt Biotherapeutics BOLT Stock Holding History

JP Morgan Chase’s Portfolio BOLT Stock Details BOLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$179 Hold
42
– – ﹤0.01% 7265
2025
Q4 		$230 Hold
42
– – ﹤0.01% 7146
2025
Q3 		$223 Sell
42
-1
-2% -$6 ﹤0.01% 7105
2025
Q2 		$251 Sell
43
-2
-4% -$13 ﹤0.01% 6763
2025
Q1 		$362 Sell
45
-1
-2% -$10 ﹤0.01% 6734
2024
Q4 		$487 Hold
46
– – ﹤0.01% 6804
2024
Q3 		$592 Buy
46
+4
+10% +$55 ﹤0.01% 6785
2024
Q2 		$630 Hold
42
– – ﹤0.01% 6663
2024
Q1 		$1.18K Hold
42
– – ﹤0.01% 6631
2023
Q4 		$941 Sell
42
-3,772
-99% -$73.4K ﹤0.01% 6840
2023
Q3 		$79.3K Sell
3,814
-2,618
-41% -$64K ﹤0.01% 5620
2023
Q2 		$165K Sell
6,432
-3,033
-32% -$96.3K ﹤0.01% 5189
2023
Q1 		$263K Buy
9,465
+8,470
+851% +$248K ﹤0.01% 4891
2022
Q4 		$26K Buy
995
+877
+743% +$24K ﹤0.01% 5799
2022
Q3 		$3K Buy
118
+46
+64% +$1.9K ﹤0.01% 6179
2022
Q2 		$3K Sell
72
-3,211
-98% -$125K ﹤0.01% 6236
2022
Q1 		$180K Buy
3,283
+40
+1% +$2.69K ﹤0.01% 5245
2021
Q4 		$318K Sell
3,243
-161
-5% -$30.6K ﹤0.01% 5095
2021
Q3 		$861K Sell
3,404
-801
-19% -$226K ﹤0.01% 4421
2021
Q2 		$1.3M Sell
4,205
-8,342
-66% -$3.39M ﹤0.01% 4118
2021
Q1 		$8.26M Buy
+12,547
New +$8.17M ﹤0.01% 2546

Other funds holding BOLT

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
TC
T3 Companies New York $76.8M AUM
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase's BOLT Position: Q1 2026 in Review

JP Morgan Chase held its Bolt Biotherapeutics (BOLT) position steady in Q1 2026 at 42 shares worth $179. The position accounts for ﹤0.01% of the portfolio, ranked #7265.

JP Morgan Chase first reported a position in BOLT in Q1 2021 and has held it in 21 quarters since. The position peaked at $8.26M in Q1 2021. 24 funds tracked by Wall St. Rank hold BOLT as of Q1 2026.

  • JP Morgan Chase held 42 shares of Bolt Biotherapeutics worth $179 as of Q1 2026.
  • JP Morgan Chase left its Bolt Biotherapeutics share count unchanged in Q1 2026.
  • Bolt Biotherapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7265 holding.
  • JP Morgan Chase first reported a position in Bolt Biotherapeutics in Q1 2021 and has held it in 21 quarters since.
  • JP Morgan Chase's Bolt Biotherapeutics position peaked at $8.26M in Q1 2021.
  • 24 funds tracked by Wall St. Rank held Bolt Biotherapeutics as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.